Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte versus Geloplasma during cardiopulmonary bypass priming
2013-005209-30Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Dec 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hetastarch and succinylated gelatin in cardiac morbidity (2 arms), sponsored by Ghent University Hospital. Primary endpoints: Microvascular reactivity measured with near-infrared spectroscopy, Oxygen consumption and 2 more. Started Dec 2013; status: completed.
02
Drugs
hetastarchsuccinylated gelatin
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2013-005209-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005209-30.